AI assistant
Sands China Ltd. — Director's Dealing 2021
Oct 29, 2021
50273_rns_2021-10-29_89ba4d34-a6ff-4098-9c1d-b25a5ed8ebdb.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
==> picture [72 x 43] intentionally omitted <==
Zhong Ji Longevity Science Group Limited 中基長壽科學集團有限公司
(Incorporated in Bermuda with limited liability)
(Stock Code: 767)
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY THE CHAIRMAN
This announcement is made by Zhong Ji Longevity Science Group Limited (the ‘‘Company’’) on a voluntary basis.
The board (the ‘‘Board’’) of directors (the ‘‘Directors’’) of the Company was notified by Mr. Yan Li (‘‘Mr. Yan’’), the chairman of the Board (the ‘‘Chairman’’) and an executive director, that on 29 October 2021, Mr. Yan acquired 511,705,175 ordinary shares of the Company (the ‘‘Share(s)’’) from Ms. Jia Rutong, a substantial shareholder of the Company, at a total consideration of approximately HK$255,852,588, representing HK$0.50 per Share (the ‘‘Acquisition’’).
Immediately following the Acquisition, Mr. Yan will hold 695,735,175 Shares, representing approximately 17.98% of the total issued share capital of the Company as at the date of this announcement. He will also hold, through Zhong Ji 1 International Medical Group (Hong Kong) Limited, convertible notes issued by the Company with a principal amount of HK$1,840,000,000, the conversion rights of which, if exercised in full at a conversion price of HK$0.2, are convertible into 9,200,000,000 Shares of the Company.
As advised by Mr. Yan, he has absolute faith in the future prospects and long-term development of the Company and may consider the possibility of further increasing his shareholding in the Company as and when appropriate, subject to applicable laws and regulations.
– 1 –
Shareholders and potential investors of the Company are advised to pay attention to investment risks and exercise caution when they deal or contemplate dealing in securities of the Company.
By order of the Board Zhong Ji Longevity Science Group Limited Yan Li Chairman
Hong Kong, 29 October 2021
As at the date of this announcement, the Directors are:
Executive Directors Mr. Yan Li (Chairman) Mr. Wang Hongxin (Chief Executive Officer) Mr. Li Xiaoshuang Ms. Cao Xie Qiong
Independent non-executive Directors Mr. Tam Ho Leung Simon Ms. Wang Weixia Mr. Chai Nan
Non-executive Directors
Dr. He Yiwu
Ms. Choi Ngai Wah
In the case of any inconsistency, the English text of this announcement shall prevail over the Chinese text.
– 2 –